Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Short term Debt (2022 - 2024)

Standard Biotools has reported Short term Debt over the past 6 years, most recently at $54.9 million for Q3 2024.

  • Quarterly Short term Debt rose 998.26% to $54.9 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $54.9 million through Sep 2024, up 998.26% year-over-year, with the annual reading at $54.5 million for FY2023, N/A changed from the prior year.
  • Short term Debt was $54.9 million for Q3 2024 at Standard Biotools, roughly flat from $54.8 million in the prior quarter.
  • Over five years, Short term Debt peaked at $54.9 million in Q3 2024 and troughed at $833000.0 in Q3 2022.
  • The 3-year median for Short term Debt is $5.0 million (2023), against an average of $25.4 million.
  • Year-over-year, Short term Debt skyrocketed 500.24% in 2023 and then surged 1095.35% in 2024.
  • A 3-year view of Short term Debt shows it stood at $833000.0 in 2022, then surged by 6446.22% to $54.5 million in 2023, then rose by 0.7% to $54.9 million in 2024.
  • Per Business Quant, the three most recent readings for LAB's Short term Debt are $54.9 million (Q3 2024), $54.8 million (Q2 2024), and $54.5 million (Q4 2023).